LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting

Karolinska Institute

Status: Completed

Conditions: Multiple Organ Failure

Study type: Observational

Funder types: Other

Identifiers

NCT01937676

K3-akuten

Details and patient eligibility

About

The purpose of this study is evaluate if K3, a novel biomarker, sampled at arrival to the emergency department can be used to predict the development of organ failure measured as SOFA score. K3 consists of lactate dehydrogenase, albumin and magnesium combined.

Enrollment: 1,250 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥18 years
• Admitted to emergency department, Karlstad Central Hospital, Sweden

Exclusion criteria

• Not in need of venous blood sample

Trial design

1,250 participants in 1 patient group

Adults admitted to ER

Description:

All adult patients admitted to emergency department during the study period.